What is happening with PEPFAR? It depends whom you askThe Trump administration's memo restricts access to HIV prevention medication PrEP, limiting its availability to pregnant and breastfeeding women only.
California Lawmakers Push to Protect Free HIV Prevention Amid Legal Threats | KQEDNew legislation aims to protect no-cost-sharing for HIV prevention treatments, crucial for reducing new infections.
Trump administration takes away life-saving HIV prevention medications from vulnerable LGBTQ+ people worldwideThe Trump administration has restricted access to PrEP under PEPFAR for most individuals, posing a serious threat to global HIV prevention efforts.
Over 1,000 on Dublin clinic's waiting list for HIV-prevention drug PrEPThere are significant delays in providing access to HIV Pre-Exposure Prophylaxis (PrEP) services, despite its proven effectiveness in reducing HIV infection risk.
What is happening with PEPFAR? It depends whom you askThe Trump administration's memo restricts access to HIV prevention medication PrEP, limiting its availability to pregnant and breastfeeding women only.
California Lawmakers Push to Protect Free HIV Prevention Amid Legal Threats | KQEDNew legislation aims to protect no-cost-sharing for HIV prevention treatments, crucial for reducing new infections.
Trump administration takes away life-saving HIV prevention medications from vulnerable LGBTQ+ people worldwideThe Trump administration has restricted access to PrEP under PEPFAR for most individuals, posing a serious threat to global HIV prevention efforts.
Over 1,000 on Dublin clinic's waiting list for HIV-prevention drug PrEPThere are significant delays in providing access to HIV Pre-Exposure Prophylaxis (PrEP) services, despite its proven effectiveness in reducing HIV infection risk.
New HIV preventive strategy sparks excitement and protests at AIDS conferenceThe new HIV prevention treatment, lenacapavir injection, showed 100% efficacy in early trials, offering an alternative to daily pills like Truvada for prevention efforts.
Injectable HIV medication: What you need to know DW 07/19/2024Injectable cabotegravir offers a new option in HIV prevention and treatment.
More good news about the twice-yearly PrEP injection - QueertyLenacapavir, a new injectable PrEP, shows promising effectiveness in trials, particularly for populations previously underserved by existing medications.
An "ultra" PrEP injection just three times a year could be on the wayApproval of new PrEP injection with potentially longer dosing intervalsResults of trial for cabotegravir ultra long-acting formulation presented at CROI 2024
New HIV preventive strategy sparks excitement and protests at AIDS conferenceThe new HIV prevention treatment, lenacapavir injection, showed 100% efficacy in early trials, offering an alternative to daily pills like Truvada for prevention efforts.
Injectable HIV medication: What you need to know DW 07/19/2024Injectable cabotegravir offers a new option in HIV prevention and treatment.
More good news about the twice-yearly PrEP injection - QueertyLenacapavir, a new injectable PrEP, shows promising effectiveness in trials, particularly for populations previously underserved by existing medications.
An "ultra" PrEP injection just three times a year could be on the wayApproval of new PrEP injection with potentially longer dosing intervalsResults of trial for cabotegravir ultra long-acting formulation presented at CROI 2024
September 27 Is National Gay Men's HIV/AIDS Awareness DayDespite overall declines in new HIV infections among gay and bisexual men, disparities remain significant, necessitating focused efforts on equitable access to prevention and treatment.